NEW YORK, Oct. 17, 2019 /PRNewswire/ -- Hepatitis C Treatment market worldwide is projected to grow by US$44.5 Billion, driven by a compounded growth of 12.9%. HCV Protease Inhibitors, one of the segments analyzed and sized in this study, displays the potential to grow at over 11.2%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$8.9 Billion by the year 2025, HCV Protease Inhibitors will bring in healthy gains adding significant momentum to global growth.
Read the full report: https://www.reportlinker.com/p05817746/?utm_source=PRN
- Representing the developed world, the United States will maintain a 11.5% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$1.8 Billion to the region's size and clout in the next 5 to 6 years. Over US$1.5 Billion worth of projected demand in the region will come from Rest of Europe markets. In Japan, HCV Protease Inhibitors will reach a market size of US$176.5 Million by the close of the analysis period. As the world's second largest economy and the new game changer in global markets, China exhibits the potential to grow at 16.2% over the next couple of years and add approximately US$10.4 Billion in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.
- Competitors identified in this market include among others, AbbVie, Inc.; Bristol-Myers Squibb Company; F. Hoffmann-La Roche AG; Gilead Sciences, Inc.; GlaxoSmithKline PLC; Johnson & Johnson; Kadmon Holdings, Inc.; Merck & Co., Inc.
Read the full report: https://www.reportlinker.com/p05817746/?utm_source=PRN
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Global Competitor Market Shares
Hepatitis C Treatment Competitor Market Share Scenario
Worldwide (in %): 2019 & 2028
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
Table 1: Hepatitis C Treatment Global Market Estimates and
Forecasts in US$ Million by Region/Country: 2018-2025
Table 2: Hepatitis C Treatment Global Retrospective Market
Scenario in US$ Million by Region/Country: 2009-2017
Table 3: Hepatitis C Treatment Market Share Shift across Key
Geographies Worldwide: 2009 VS 2019 VS 2025
Table 4: HCV Protease Inhibitors (Drug Class) World Market by
Region/Country in US$ Million: 2018 to 2025
Table 5: HCV Protease Inhibitors (Drug Class) Historic Market
Analysis by Region/Country in US$ Million: 2009 to 2017
Table 6: HCV Protease Inhibitors (Drug Class) Market Share
Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS
2025
Table 7: HCV Polymerase Inhibitors (Drug Class) Potential
Growth Markets Worldwide in US$ Million: 2018 to 2025
Table 8: HCV Polymerase Inhibitors (Drug Class) Historic Market
Perspective by Region/Country in US$ Million: 2009 to 2017
Table 9: HCV Polymerase Inhibitors (Drug Class) Market Sales
Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025
Table 10: HCV NS5A Inhibitors (Drug Class) Geographic Market
Spread Worldwide in US$ Million: 2018 to 2025
Table 11: HCV NS5A Inhibitors (Drug Class) Region Wise
Breakdown of Global Historic Demand in US$ Million: 2009 to
2017
Table 12: HCV NS5A Inhibitors (Drug Class) Market Share
Distribution in Percentage by Region/Country: 2009 VS 2019 VS
2025
Table 13: Combination Therapy (Drug Class) World Market
Estimates and Forecasts by Region/Country in US$ Million: 2018
to 2025
Table 14: Combination Therapy (Drug Class) Market Historic
Review by Region/Country in US$ Million: 2009 to 2017
Table 15: Combination Therapy (Drug Class) Market Share
Breakdown by Region/Country: 2009 VS 2019 VS 2025
Table 16: Interferon & Antiviral (Drug Class) World Market by
Region/Country in US$ Million: 2018 to 2025
Table 17: Interferon & Antiviral (Drug Class) Historic Market
Analysis by Region/Country in US$ Million: 2009 to 2017
Table 18: Interferon & Antiviral (Drug Class) Market Share
Distribution in Percentage by Region/Country: 2009 VS 2019 VS
2025
III. MARKET ANALYSIS
GEOGRAPHIC MARKET ANALYSIS
UNITED STATES
Market Facts & Figures
US Hepatitis C Treatment Market Share (in %) by Company: 2019 &
2025
Table 19: United States Hepatitis C Treatment Market Estimates
and Projections in US$ Million by Drug Class: 2018 to 2025
Table 20: Hepatitis C Treatment Market in the United States by
Drug Class: A Historic Review in US$ Million for 2009-2017
Table 21: United States Hepatitis C Treatment Market Share
Breakdown by Drug Class: 2009 VS 2019 VS 2025
CANADA
Table 22: Canadian Hepatitis C Treatment Market Estimates and
Forecasts in US$ Million by Drug Class: 2018 to 2025
Table 23: Canadian Hepatitis C Treatment Historic Market Review
by Drug Class in US$ Million: 2009-2017
Table 24: Hepatitis C Treatment Market in Canada: Percentage
Share Breakdown of Sales by Drug Class for 2009, 2019, and 2025
JAPAN
Table 25: Japanese Market for Hepatitis C Treatment: Annual
Sales Estimates and Projections in US$ Million by Drug Class
for the Period 2018-2025
Table 26: Hepatitis C Treatment Market in Japan: Historic Sales
Analysis in US$ Million by Drug Class for the Period 2009-2017
Table 27: Japanese Hepatitis C Treatment Market Share Analysis
by Drug Class: 2009 VS 2019 VS 2025
CHINA
Table 28: Chinese Hepatitis C Treatment Market Growth Prospects
in US$ Million by Drug Class for the Period 2018-2025
Table 29: Hepatitis C Treatment Historic Market Analysis in
China in US$ Million by Drug Class: 2009-2017
Table 30: Chinese Hepatitis C Treatment Market by Drug Class:
Percentage Breakdown of Sales for 2009, 2019, and 2025
EUROPE
Market Facts & Figures
European Hepatitis C Treatment Market: Competitor Market Share
Scenario (in %) for 2019 & 2025
Table 31: European Hepatitis C Treatment Market Demand Scenario
in US$ Million by Region/Country: 2018-2025
Table 32: Hepatitis C Treatment Market in Europe: A Historic
Market Perspective in US$ Million by Region/Country for the
Period 2009-2017
Table 33: European Hepatitis C Treatment Market Share Shift by
Region/Country: 2009 VS 2019 VS 2025
Table 34: European Hepatitis C Treatment Market Estimates and
Forecasts in US$ Million by Drug Class: 2018-2025
Table 35: Hepatitis C Treatment Market in Europe in US$ Million
by Drug Class: A Historic Review for the Period 2009-2017
Table 36: European Hepatitis C Treatment Market Share Breakdown
by Drug Class: 2009 VS 2019 VS 2025
FRANCE
Table 37: Hepatitis C Treatment Market in France by Drug Class:
Estimates and Projections in US$ Million for the Period
2018-2025
Table 38: French Hepatitis C Treatment Historic Market Scenario
in US$ Million by Drug Class: 2009-2017
Table 39: French Hepatitis C Treatment Market Share Analysis by
Drug Class: 2009 VS 2019 VS 2025
GERMANY
Table 40: Hepatitis C Treatment Market in Germany: Recent Past,
Current and Future Analysis in US$ Million by Drug Class for
the Period 2018-2025
Table 41: German Hepatitis C Treatment Historic Market Analysis
in US$ Million by Drug Class: 2009-2017
Table 42: German Hepatitis C Treatment Market Share Breakdown
by Drug Class: 2009 VS 2019 VS 2025
ITALY
Table 43: Italian Hepatitis C Treatment Market Growth Prospects
in US$ Million by Drug Class for the Period 2018-2025
Table 44: Hepatitis C Treatment Historic Market Analysis in
Italy in US$ Million by Drug Class: 2009-2017
Table 45: Italian Hepatitis C Treatment Market by Drug Class:
Percentage Breakdown of Sales for 2009, 2019, and 2025
UNITED KINGDOM
Table 46: United Kingdom Market for Hepatitis C Treatment:
Annual Sales Estimates and Projections in US$ Million by Drug
Class for the Period 2018-2025
Table 47: Hepatitis C Treatment Market in the United Kingdom:
Historic Sales Analysis in US$ Million by Drug Class for the
Period 2009-2017
Table 48: United Kingdom Hepatitis C Treatment Market Share
Analysis by Drug Class: 2009 VS 2019 VS 2025
SPAIN
Table 49: Spanish Hepatitis C Treatment Market Estimates and
Forecasts in US$ Million by Drug Class: 2018 to 2025
Table 50: Spanish Hepatitis C Treatment Historic Market Review
by Drug Class in US$ Million: 2009-2017
Table 51: Hepatitis C Treatment Market in Spain: Percentage
Share Breakdown of Sales by Drug Class for 2009, 2019, and 2025
RUSSIA
Table 52: Russian Hepatitis C Treatment Market Estimates and
Projections in US$ Million by Drug Class: 2018 to 2025
Table 53: Hepatitis C Treatment Market in Russia by Drug Class:
A Historic Review in US$ Million for 2009-2017
Table 54: Russian Hepatitis C Treatment Market Share Breakdown
by Drug Class: 2009 VS 2019 VS 2025
REST OF EUROPE
Table 55: Rest of Europe Hepatitis C Treatment Market Estimates
and Forecasts in US$ Million by Drug Class: 2018-2025
Table 56: Hepatitis C Treatment Market in Rest of Europe in US$
Million by Drug Class: A Historic Review for the Period
2009-2017
Table 57: Rest of Europe Hepatitis C Treatment Market Share
Breakdown by Drug Class: 2009 VS 2019 VS 2025
ASIA-PACIFIC
Table 58: Asia-Pacific Hepatitis C Treatment Market Estimates
and Forecasts in US$ Million by Region/Country: 2018-2025
Table 59: Hepatitis C Treatment Market in Asia-Pacific:
Historic Market Analysis in US$ Million by Region/Country for
the Period 2009-2017
Table 60: Asia-Pacific Hepatitis C Treatment Market Share
Analysis by Region/Country: 2009 VS 2019 VS 2025
Table 61: Hepatitis C Treatment Market in Asia-Pacific by Drug
Class: Estimates and Projections in US$ Million for the Period
2018-2025
Table 62: Asia-Pacific Hepatitis C Treatment Historic Market
Scenario in US$ Million by Drug Class: 2009-2017
Table 63: Asia-Pacific Hepatitis C Treatment Market Share
Analysis by Drug Class: 2009 VS 2019 VS 2025
AUSTRALIA
Table 64: Hepatitis C Treatment Market in Australia: Recent
Past, Current and Future Analysis in US$ Million by Drug Class
for the Period 2018-2025
Table 65: Australian Hepatitis C Treatment Historic Market
Analysis in US$ Million by Drug Class: 2009-2017
Table 66: Australian Hepatitis C Treatment Market Share
Breakdown by Drug Class: 2009 VS 2019 VS 2025
INDIA
Table 67: Indian Hepatitis C Treatment Market Estimates and
Forecasts in US$ Million by Drug Class: 2018 to 2025
Table 68: Indian Hepatitis C Treatment Historic Market Review
by Drug Class in US$ Million: 2009-2017
Table 69: Hepatitis C Treatment Market in India: Percentage
Share Breakdown of Sales by Drug Class for 2009, 2019, and 2025
SOUTH KOREA
Table 70: Hepatitis C Treatment Market in South Korea: Recent
Past, Current and Future Analysis in US$ Million by Drug Class
for the Period 2018-2025
Table 71: South Korean Hepatitis C Treatment Historic Market
Analysis in US$ Million by Drug Class: 2009-2017
Table 72: Hepatitis C Treatment Market Share Distribution in
South Korea by Drug Class: 2009 VS 2019 VS 2025
REST OF ASIA-PACIFIC
Table 73: Rest of Asia-Pacific Market for Hepatitis C
Treatment: Annual Sales Estimates and Projections in US$
Million by Drug Class for the Period 2018-2025
Table 74: Hepatitis C Treatment Market in Rest of Asia-Pacific:
Historic Sales Analysis in US$ Million by Drug Class for the
Period 2009-2017
Table 75: Rest of Asia-Pacific Hepatitis C Treatment Market
Share Analysis by Drug Class: 2009 VS 2019 VS 2025
LATIN AMERICA
Table 76: Latin American Hepatitis C Treatment Market Trends by
Region/Country in US$ Million: 2018-2025
Table 77: Hepatitis C Treatment Market in Latin America in US$
Million by Region/Country: A Historic Perspective for the
Period 2009-2017
Table 78: Latin American Hepatitis C Treatment Market
Percentage Breakdown of Sales by Region/Country: 2009, 2019,
and 2025
Table 79: Latin American Hepatitis C Treatment Market Growth
Prospects in US$ Million by Drug Class for the Period 2018-2025
Table 80: Hepatitis C Treatment Historic Market Analysis in
Latin America in US$ Million by Drug Class: 2009-2017
Table 81: Latin American Hepatitis C Treatment Market by Drug
Class: Percentage Breakdown of Sales for 2009, 2019, and 2025
ARGENTINA
Table 82: Argentinean Hepatitis C Treatment Market Estimates
and Forecasts in US$ Million by Drug Class: 2018-2025
Table 83: Hepatitis C Treatment Market in Argentina in US$
Million by Drug Class: A Historic Review for the Period
2009-2017
Table 84: Argentinean Hepatitis C Treatment Market Share
Breakdown by Drug Class: 2009 VS 2019 VS 2025
BRAZIL
Table 85: Hepatitis C Treatment Market in Brazil by Drug Class:
Estimates and Projections in US$ Million for the Period
2018-2025
Table 86: Brazilian Hepatitis C Treatment Historic Market
Scenario in US$ Million by Drug Class: 2009-2017
Table 87: Brazilian Hepatitis C Treatment Market Share Analysis
by Drug Class: 2009 VS 2019 VS 2025
MEXICO
Table 88: Hepatitis C Treatment Market in Mexico: Recent Past,
Current and Future Analysis in US$ Million by Drug Class for
the Period 2018-2025
Table 89: Mexican Hepatitis C Treatment Historic Market
Analysis in US$ Million by Drug Class: 2009-2017
Table 90: Mexican Hepatitis C Treatment Market Share Breakdown
by Drug Class: 2009 VS 2019 VS 2025
REST OF LATIN AMERICA
Table 91: Rest of Latin America Hepatitis C Treatment Market
Estimates and Projections in US$ Million by Drug Class: 2018 to
2025
Table 92: Hepatitis C Treatment Market in Rest of Latin America
by Drug Class: A Historic Review in US$ Million for 2009-2017
Table 93: Rest of Latin America Hepatitis C Treatment Market
Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
MIDDLE EAST
Table 94: The Middle East Hepatitis C Treatment Market
Estimates and Forecasts in US$ Million by Region/Country:
2018-2025
Table 95: Hepatitis C Treatment Market in the Middle East by
Region/Country in US$ Million: 2009-2017
Table 96: The Middle East Hepatitis C Treatment Market Share
Breakdown by Region/Country: 2009, 2019, and 2025
Table 97: The Middle East Hepatitis C Treatment Market
Estimates and Forecasts in US$ Million by Drug Class: 2018 to
2025
Table 98: The Middle East Hepatitis C Treatment Historic Market
by Drug Class in US$ Million: 2009-2017
Table 99: Hepatitis C Treatment Market in the Middle East:
Percentage Share Breakdown of Sales by Drug Class for 2009,
2019, and 2025
IRAN
Table 100: Iranian Market for Hepatitis C Treatment: Annual
Sales Estimates and Projections in US$ Million by Drug Class
for the Period 2018-2025
Table 101: Hepatitis C Treatment Market in Iran: Historic Sales
Analysis in US$ Million by Drug Class for the Period 2009-2017
Table 102: Iranian Hepatitis C Treatment Market Share Analysis
by Drug Class: 2009 VS 2019 VS 2025
ISRAEL
Table 103: Israeli Hepatitis C Treatment Market Estimates and
Forecasts in US$ Million by Drug Class: 2018-2025
Table 104: Hepatitis C Treatment Market in Israel in US$
Million by Drug Class: A Historic Review for the Period
2009-2017
Table 105: Israeli Hepatitis C Treatment Market Share Breakdown
by Drug Class: 2009 VS 2019 VS 2025
SAUDI ARABIA
Table 106: Saudi Arabian Hepatitis C Treatment Market Growth
Prospects in US$ Million by Drug Class for the Period 2018-2025
Table 107: Hepatitis C Treatment Historic Market Analysis in
Saudi Arabia in US$ Million by Drug Class: 2009-2017
Table 108: Saudi Arabian Hepatitis C Treatment Market by Drug
Class: Percentage Breakdown of Sales for 2009, 2019, and 2025
UNITED ARAB EMIRATES
Table 109: Hepatitis C Treatment Market in the United Arab
Emirates: Recent Past, Current and Future Analysis in US$
Million by Drug Class for the Period 2018-2025
Table 110: United Arab Emirates Hepatitis C Treatment Historic
Market Analysis in US$ Million by Drug Class: 2009-2017
Table 111: Hepatitis C Treatment Market Share Distribution in
United Arab Emirates by Drug Class: 2009 VS 2019 VS 2025
REST OF MIDDLE EAST
Table 112: Hepatitis C Treatment Market in Rest of Middle East:
Recent Past, Current and Future Analysis in US$ Million by Drug
Class for the Period 2018-2025
Table 113: Rest of Middle East Hepatitis C Treatment Historic
Market Analysis in US$ Million by Drug Class: 2009-2017
Table 114: Rest of Middle East Hepatitis C Treatment Market
Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
AFRICA
Table 115: African Hepatitis C Treatment Market Estimates and
Projections in US$ Million by Drug Class: 2018 to 2025
Table 116: Hepatitis C Treatment Market in Africa by Drug
Class: A Historic Review in US$ Million for 2009-2017
Table 117: African Hepatitis C Treatment Market Share Breakdown
by Drug Class: 2009 VS 2019 VS 2025
IV. COMPETITION
ABBVIE
BRISTOL-MYERS SQUIBB COMPANY
F. HOFFMANN-LA ROCHE AG
GILEAD SCIENCES
GLAXOSMITHKLINE PLC
JOHNSON & JOHNSON
KADMON HOLDINGS, INC.
MERCK & CO., INC.
V. CURATED RESEARCH
Read the full report: https://www.reportlinker.com/p05817746/?utm_source=PRN
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001
SOURCE Reportlinker
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article